DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹5,655 Cr | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr |
What is the latest Consolidated Net Profit of DR REDDYS LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹5,655 Cr |
| Mar2025 | ₹5,578 Cr |
| Mar2024 | ₹4,507 Cr |
| Mar2023 | ₹2,183 Cr |
| Mar2022 | ₹1,952 Cr |
How is Consolidated Net Profit of DR REDDYS LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,655 Cr | 1.38 | |
| Mar2025 | ₹5,578 Cr | 23.75 | |
| Mar2024 | ₹4,507 Cr | 106.52 | |
| Mar2023 | ₹2,183 Cr | 11.83 | |
| Mar2022 | ₹1,952 Cr | - | |
Compare Consolidated Net Profit of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹96,908.7 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| MANKIND PHARMA | ₹98,304.7 Cr | -1.4% | -4.6% | -4.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -1.3% |
0.1% |
-7.8% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses